Baby Skin Care Trial: a study comparing an infant skin-cleansing product with water
- Conditions
- Atopic eczema/ atopic dermatitisSkin and Connective Tissue DiseasesAtopic dermatitis
- Registration Number
- ISRCTN72285670
- Lead Sponsor
- iverpool Women's NHS Foundation Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 280
1. Screening phase:
1.1. Women carrying singleton pregnancies who are booked to give birth at the study hospital
2. Trial phase:
2.1. Babies (both males and females) born between 37 weeks and 41 weeks
2.2. In good general health (as determined by the investigator)
1. Screening phase:
1.1. Women known to be carrying a baby with a chromosomal abnormality or other syndromic diagnosis
1.2. Women known to be having their baby adopted
2. Trial phase:
2.1. Admission to the neonatal unit
2.2. Phototherapy
2.3. Limb defects
2.4. Non-traumatic impairment of epidermal integrity, evidence of skin disorder at first visit. For the purposes of this study the following normal variations will not be considered skin disorders ? erythema neonatorum / erythema toxicum
2.5. Milia
2.6. Maternal age <18
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of change in trans-epidermal water loss (TEWL) measurement from the first bath until day 56 after birth. TEWL is defined as the flux of condensed water diffusing through the skin. <br><br>(Added 12/01/10):<br>Average of the TEWL measurements over three sites (arm, leg and abdomen) will be calculated.<br><br>Follow up will take place at 2 and 4 weeks following birth. This will include assessment of all primary and secondary outcome measures.
- Secondary Outcome Measures
Name Time Method 1. Acceptability of intervention The views of mothers and significant others on smell, perception of cleanliness, perception of skin's moisture, measured using a specifically designed questionnaire and diaries which have gained content validity by being informed by the earlier qualitative work <br>2. Skin surface pH<br>3. Measurement of hydration<br>4. Change in clinical observations (erythema, dryness and scaling, need for medical products/ attention)<br><br>Follow up will take place at 2 and 4 weeks following birth. This will include assessment of all primary and secondary outcome measures.